title: Letter by Alexopoulos et al regarding article, "pharmacodynamic effect of switching therapy in patients with high on-treatment platelet reactivity and genotype variation with high clopidogrel dose versus prasugrel: the RESET GENE Trial".
authors: Dimitrios
authors: D
authors: Alexopoulos
authors: Ioanna
authors: I
authors: Xanthopoulou
mesh_terms: D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D001792:Blood Platelets / Q000187:drug effects*; D003324:Coronary Artery Disease / Q000628:therapy*; D057915:Drug Substitution; D005260:Female; D006801:Humans; D008297:Male; D017202:Myocardial Ischemia / Q000517:prevention & control*; D062645:Percutaneous Coronary Intervention; D010879:Piperazines / Q000008:administration & dosage*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage*; D013876:Thiophenes / Q000008:administration & dosage*; D013988:Ticlopidine / Q000031:analogs & derivatives*
chemical_list: D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D013876:Thiophenes; D001189:Aryl Hydrocarbon Hydroxylases; D013988:Ticlopidine